“Breakthrough” Designation: FDA Clarifies How To Get It – And How It Can Be Lost
This article was originally published in The Pink Sheet Daily
Executive Summary
“Preliminary clinical evidence” should demonstrate substantial improvement in effectiveness or safety over available therapies but likely will not be sufficient to support approval, final guidance explains.